I was interviewed for the recent cure magazine feature on living with metastatic breast cancer.
The Estrogen Effect: New Ways to Treat Hormone-Positive Breast Cancer
BY HEATHER L. VAN EPPS, PHD
PUBLISHED SEPTEMBER 13, 2012
Patients with ER-positive breast cancer have more potential treatments with new therapies and combinations.
In the late 1970s, treatment of hormone receptor-positive breast cancer was revolutionized by the introduction of the drug tamoxifen. Since then, a multitude of successful new hormone-based (endocrine) drugs have followed. But despite this formidable arsenal, not all patients respond to these drugs, and many who do respond eventually relapse.
This was the case for 53-year-old Seattle resident Jill Cohen. In 2002, doctors discovered that her breast cancer—initially diagnosed as early-stage disease in 1998—had returned and spread to her bones. Cohen is alive thanks to a series of hormone therapy drugs.
“I feel extraordinarily lucky,” Cohen says. “I have long outlived the statistical odds.”
To read the rest of the article, or to request a copy, click here. CURE Magazine is widely available in oncologists' offices and treatment centers.